# Cockroach Immunotherapy in Children and Adolescents

> **NCT03541187** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 82 (actual)

## Conditions studied

- Persistent Asthma

## Interventions

- **BIOLOGICAL:** German cockroach allergenic extract
- **BIOLOGICAL:** Placebo for German cockroach allergenic extract

## Key facts

- **NCT ID:** NCT03541187
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-16
- **Primary completion:** 2022-06-02
- **Final completion:** 2022-06-03
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2023-05-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03541187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03541187, "Cockroach Immunotherapy in Children and Adolescents". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03541187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*